Top compounds associated with response to HLA-DMA


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA fingolimod CTRPv2 pan-cancer AAC 0.089 0.02
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA ZSTK474 CTRPv2 pan-cancer AAC 0.092 0.02
mRNA ML083 CTRPv2 pan-cancer AAC 0.095 0.02
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.02
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.093 0.02
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.08 0.03
Download CSV